HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine Boileau Selected Research

Antibodies

10/2017PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies.
3/2011Association study of 3 rheumatoid arthritis risk loci in systemic sclerosis in European Caucasian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine Boileau Research Topics

Disease

29Marfan Syndrome (Marfan's Syndrome)
03/2024 - 04/2002
22Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
05/2022 - 08/2002
12Thoracic Aortic Aneurysm
12/2021 - 08/2006
12Systemic Scleroderma (Systemic Sclerosis)
05/2012 - 12/2007
10Hypercholesterolemia
10/2023 - 11/2005
9Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 11/2005
6Neoplasms (Cancer)
08/2015 - 08/2004
5Loeys-Dietz Syndrome
01/2022 - 08/2006
5Aortic Dissection
01/2022 - 12/2009
5Coronary Disease (Coronary Heart Disease)
01/2021 - 06/2003
5Aortic Diseases
01/2020 - 01/2015
4Dyslipidemias (Dyslipidemia)
12/2023 - 12/2016
4Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 03/2011
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 02/2015
3Fibrosis (Cirrhosis)
11/2023 - 12/2007
3Disease Progression
10/2023 - 04/2005
3Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
05/2022 - 01/2013
3Inborn Genetic Diseases (Disease, Hereditary)
03/2022 - 01/2003
3Aneurysm (Aneurysms)
01/2022 - 05/2005
3Aortic Aneurysm (Aneurysm, Aortic)
12/2021 - 04/2015
3Rheumatoid Arthritis
01/2021 - 01/2014
2Acromicric dysplasia
03/2024 - 11/2022
2Atherosclerosis
12/2023 - 02/2015
2Rare Diseases (Rare Disease)
10/2023 - 02/2009
2Vascular Remodeling
12/2021 - 11/2011
2Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2021 - 01/2013
2Ectopia Lentis
01/2021 - 05/2015
2Sudden Death
08/2015 - 12/2009
2Xanthomatosis (Xanthoma)
08/2014 - 12/2013
2Hypoxia (Hypoxemia)
11/2011 - 08/2011
2Diffuse Scleroderma (Progressive Systemic Sclerosis)
08/2011 - 04/2010
2Connective Tissue Diseases (Connective Tissue Disease)
01/2011 - 11/2010
2Insulin Resistance
08/2007 - 04/2007
2Dyspnea (Shortness of Breath)
01/2005 - 10/2004
1Liver Diseases (Liver Disease)
11/2023
1COVID-19
07/2023
1Non-alcoholic Fatty Liver Disease
01/2022
1Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial)
01/2022
1Iron Overload
01/2022
1Abdominal Aortic Aneurysm
12/2021
1Hypobetalipoproteinemias (Hypobetalipoproteinemia)
08/2021

Drug/Important Bio-Agent (IBA)

14LDL CholesterolIBA
05/2022 - 06/2003
13Fibrillin-1IBA
03/2024 - 04/2002
11Apolipoproteins B (ApoB)IBA
03/2022 - 01/2003
11Transforming Growth Factor-beta Type II ReceptorIBA
01/2022 - 08/2004
11ApolipoproteinsIBA
08/2021 - 01/2003
9oxidized low density lipoproteinIBA
10/2023 - 11/2005
9Proprotein Convertase 9IBA
01/2020 - 06/2003
9LDL Receptors (LDL Receptor)IBA
01/2018 - 08/2002
7Proteins (Proteins, Gene)FDA Link
03/2024 - 12/2007
7Transforming Growth Factor-beta Type I ReceptorIBA
01/2022 - 08/2006
7CholesterolIBA
10/2017 - 11/2005
6Apolipoproteins E (ApoE)IBA
12/2023 - 01/2013
6Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
01/2017 - 07/2009
5SubtilisinIBA
01/2017 - 11/2010
5LDL Lipoproteins (beta Lipoproteins)IBA
01/2013 - 04/2009
4Triglycerides (Triacylglycerol)IBA
05/2022 - 01/2013
4Lipoproteins (Lipoprotein)IBA
01/2022 - 01/2019
4LipidsIBA
10/2017 - 04/2007
3Angiotensin Receptor AntagonistsIBA
10/2022 - 05/2010
31,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
01/2021 - 08/2006
3AutoantibodiesIBA
01/2014 - 12/2007
3Biomarkers (Surrogate Marker)IBA
03/2012 - 03/2008
3FibrillinsIBA
02/2009 - 09/2003
2Messenger RNA (mRNA)IBA
07/2023 - 05/2015
2Angiotensin II Type 1 Receptor BlockersIBA
01/2023 - 05/2010
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 08/2015
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 08/2011
2Amino AcidsFDA Link
04/2020 - 01/2015
2alirocumabIBA
01/2020 - 12/2015
2Metalloproteases (Metalloproteinases)IBA
12/2018 - 03/2010
2AntibodiesIBA
10/2017 - 03/2011
2Monoclonal AntibodiesIBA
01/2017 - 12/2015
2Oxidoreductases (Dehydrogenase)IBA
03/2016 - 10/2005
2Losartan (Cozaar)FDA LinkGeneric
08/2015 - 05/2010
2Apolipoprotein B-100 (Apo B 100)IBA
12/2012 - 05/2012
2erucylphosphocholineIBA
03/2012 - 11/2011
2CollagenIBA
01/2011 - 11/2010
2LigandsIBA
07/2009 - 04/2009
2Transforming Growth Factor beta (TGF-beta)IBA
02/2009 - 12/2007
2Glucose (Dextrose)FDA LinkGeneric
08/2007 - 04/2007
2Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
08/2006 - 08/2004
2Brain Natriuretic Peptide (Natrecor)FDA Link
01/2005 - 10/2004
1Carrier Proteins (Binding Protein)IBA
03/2024
1Transaminases (Aminotransferases)IBA
11/2023
1CI 22IBA
07/2023
1VaccinesIBA
07/2023
1Ad26COVS1IBA
07/2023
12019-nCoV Vaccine mRNA-1273IBA
07/2023
1BNT162 VaccineIBA
07/2023
1IronIBA
01/2022
1ChylomicronsIBA
01/2022
1ADAMTS ProteinsIBA
12/2021
1Nonsense Codon (Nonsense Mutation)IBA
01/2021

Therapy/Procedure

12Therapeutics
10/2023 - 03/2008
2Precision Medicine
10/2023 - 01/2020
1Liver Transplantation
11/2023
1Investigational Therapies (Experimental Therapy)
10/2023
1Bariatric Surgery
01/2022
1Lung Transplantation
01/2022